Vopak reported 1Q25 which were in line with proportional EBITDA of €300m vs consensus of €292m. So far company foresees only limited impact in the short term linked to trade tariff uncertainty. EBITDA outlook maintained even when discounting less favourable FX rates. Indian AVTL on track for IPO in 1H25 following conditional approval by regulator. Occupancy rates holding up well at 92% vs. 93% last quarter. The Q&A in the analyst call further comforted our scenario. We reiterate Buy rating and €...
Resolutions passed by Vopak’s Annual General Meeting Resolutions passed by Vopak’s Annual General MeetingRotterdam, the Netherlands, 23 April 2025 The Annual General Meeting of Koninklijke Vopak N.V. (Royal Vopak) held on 23 April 2025 passed the following resolutions: Positive advisory vote implementation remuneration policy for the 2024 financial year. Adoption of the financial statements for the 2024 financial year. Approval of the proposed dividend. A dividend of EUR 1.60 per ordinary share with a nominal value of EUR 0.50 will be distributed wholly in cash on 2 May 2025. As fro...
CMB.TECH and Golden Ocean have signed a term sheet for a contemplated stock-for-stock merger at an exchange ratio of 0.95 CMB.TECH shares for each outstanding Golden Ocean share. Completion is scheduled for Q3, and the companies are scheduled to host CMDs on 24 and 29 April to provide further information. As DNB Markets is acting as financial advisor to Golden Ocean, we have withdrawn our recommendation and target price.
AkzoNobel: 3% beat on 1Q25 Adj. EBITDA, FY25 guidance maintained at +€1.55bn. BE Semiconductor Industries: 1Q25 results - extending the downcycle. Corbion: Apogee. Just Eat Takeaway.com: 1Q25 Trading Update - no impact on the bid. Kinepolis: 1Q25 preview. KPN: 1Q25 preview. Randstad: Strong 9% high quality beat on 1Q25, 2Q25 outlook looks a touch below. Vår Energi: Fine start of the year, more to come. Vopak: Reasonable start, cashflow developing nicely.
Akzo's 1Q adjusted EBITDA decreased by 2% and came in c. 3% below our forecast and c. 3% above consensus. FY25 adj EBITDA guidance of above €1555m is maintained and calls for at least 5% growth, whilst most of the predicted growth comes from self help measures. Taking into account the volatile track record and low structural growth, we maintain our Hold rating and € 65 TP.
Corbion announced much better than expected 1Q results, with adjusted EBITDA up 58% and about 20% better than our forecast and 23% above consensus. Whilst 1Q results were partly aided by phasing, Corbion reiterated FY25 guidance of >25% adj EBITDA growth. We appreciate Corbion for its leading position in lactic acid and consider valuation to be attractive. We maintain our Accumulate rating and € 26 TP.
The volatility caused by initial trade war worries in 1Q25 is expected to result in a solid quarter; though partially compensated by more subdued digital assets trading. The market turmoil created by the reciprocal tariff announcement on April 2nd will result in a very strong 2Q25, hinting back to what we saw in 2020. Although visibility going forward is very limited, our base case assumes continued elevated volatility & trading levels until at least the November 2026 US Congress elections. Our ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.